NO20030133L - Ny aerosolformulering inneholdende et polart fluorert molekyl - Google Patents

Ny aerosolformulering inneholdende et polart fluorert molekyl

Info

Publication number: NO20030133L
Authority: NO; Norway
Prior art keywords: aerosol formulation; formulation containing; polar fluorinated; new aerosol; fluorinated molecule
Prior art date: 2000-07-11

Application number

NO20030133A

Other languages

English (en)

Norwegian (no)

Other versions

NO20030133D0 (no

Inventor

Philippe Rogueda

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-11

Filing date

2003-01-10

Publication date

2003-02-24

2003-01-10 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-01-10 Publication of NO20030133D0 publication Critical patent/NO20030133D0/no

2003-02-24 Publication of NO20030133L publication Critical patent/NO20030133L/no

Links

239000000203 mixture Substances 0.000 title abstract 4
238000009472 formulation Methods 0.000 title abstract 3
239000000443 aerosol Substances 0.000 title 1
239000003380 propellant Substances 0.000 abstract 2
YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 abstract 1
LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical group FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
239000008249 pharmaceutical aerosol Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Otolaryngology (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Dispersion Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20030133A 2000-07-11 2003-01-10 Ny aerosolformulering inneholdende et polart fluorert molekyl NO20030133L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0016876.5A GB0016876D0 (en)	2000-07-11	2000-07-11	Novel formulation
PCT/SE2001/001606 WO2002003958A1 (fr)	2000-07-11	2001-07-10	Nouvelle preparation en aerosol contenant une molecule fluoree polaire

Publications (2)

Publication Number	Publication Date
NO20030133D0 NO20030133D0 (no)	2003-01-10
NO20030133L true NO20030133L (no)	2003-02-24

Family

ID=9895336

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030133A NO20030133L (no)	2000-07-11	2003-01-10	Ny aerosolformulering inneholdende et polart fluorert molekyl

Country Status (21)

Country	Link
US (1)	US20030194378A1 (fr)
EP (1)	EP1303258B1 (fr)
JP (1)	JP2004502719A (fr)
KR (1)	KR20030025265A (fr)
CN (1)	CN1455663A (fr)
AT (1)	ATE342048T1 (fr)
AU (2)	AU2001272866B2 (fr)
BR (1)	BR0112322A (fr)
CA (1)	CA2415092A1 (fr)
CY (1)	CY1105913T1 (fr)
DE (1)	DE60123793T2 (fr)
DK (1)	DK1303258T3 (fr)
ES (1)	ES2273864T3 (fr)
GB (1)	GB0016876D0 (fr)
IL (2)	IL153726A0 (fr)
MX (1)	MXPA03000276A (fr)
NO (1)	NO20030133L (fr)
NZ (1)	NZ523379A (fr)
PT (1)	PT1303258E (fr)
WO (1)	WO2002003958A1 (fr)
ZA (1)	ZA200300075B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH0759042A (ja) *	1993-08-13	1995-03-03	Toshiba Corp	画像保管装置
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
US6983749B2 (en) *	2001-12-04	2006-01-10	Minnesota High-Tech Resources, Llc	Inducing hypothermia and rewarming using a helium-oxygen mixture
CA2470520A1 (fr)	2001-12-21	2003-07-24	3M Innovative Properties Company	Compositions aerosols pharmaceutiques comportant un excipient au polyethylene-glycol fonctionnalise
SE0200312D0 (sv)	2002-02-01	2002-02-01	Astrazeneca Ab	Novel composition
CA2474690A1 (fr) *	2002-02-01	2003-08-07	Astrazeneca Ab	Composition pour inhalation
SE0203376D0 (sv) *	2002-11-15	2002-11-15	Astrazeneca Ab	New process
FR2851166A1 (fr) *	2003-02-13	2004-08-20	D Lab	Utilisation d'un liquide volatil a pression atmospherique et a temperature ambiante pour la fabrication de compositions pharmaceutiques et/ou biologiques
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
US20070020299A1 (en)	2003-12-31	2007-01-25	Pipkin James D	Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20060188729A1 (en) *	2005-02-22	2006-08-24	Kai-Volker Schubert	Washable leather with repellency
DE102007025898A1 (de) *	2007-06-01	2008-12-04	Matthias W. Dr. Amrein	Behandlung von Surfactanten
WO2008152398A2 (fr) *	2007-06-14	2008-12-18	Cipla Limited	Formulations pour inhalation
ES2493641T3 (es) *	2007-06-28	2014-09-12	Cydex Pharmaceuticals, Inc.	Administración nasal de soluciones acuosas de corticosteroides
US20090012250A1 (en) *	2007-07-03	2009-01-08	Yu-Chin Lai	Novel polymerizable surface active monomers with both fluorine-containing groups and hydrophilic groups
KR100910848B1 (ko) *	2007-09-13	2009-08-06	재단법인서울대학교산학협력재단	알러지성 비염 치료약물을 유효성분으로 함유하는 비강분무용 마이크로스피어 및 이의 제조방법
US8586007B2 (en)	2007-10-19	2013-11-19	Wayne State University	Co-polymer stabilizers for hydrofluoroalkane dispersions
ES2588952T3 (es) *	2008-04-28	2016-11-07	Al.Chi.Mi.A. S.R.L.	Fluoroalquiloxi alcanos, proceso para su producción y usos de los mismos
US20120219596A1 (en)	2009-07-30	2012-08-30	Wendelin Stark	Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
CN102574958B (zh) *	2009-10-09	2014-07-16	株式会社吴羽	新的1,1-二氟乙烯共聚物及其制造方法
EP2407150A1 (fr) *	2010-07-16	2012-01-18	Justus-Liebig-Universität Gießen	Nano- et microparticules polymèriques pour maintenir la tension de surface dans les poumons et pour la protection de les tensioactifs pulmonaire
US9481643B2 (en)	2012-07-18	2016-11-01	Merck Patent Gmbh	Fluorosurfactants
KR101516057B1 (ko) *	2012-12-07	2015-04-30	가톨릭대학교 산학협력단	폐질환 치료용 흡입 제형 및 이의 제조방법
CN109464429B (zh) *	2018-12-13	2021-04-27	上海方予健康医药科技有限公司	一种吸入压力定量气雾剂药物组合物及其制备方法
CA3134504A1 (fr) *	2019-04-01	2020-10-08	Honeywell International Inc.	Compositions, procedes et dispositifs d'aerosol de soins personnels

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3557294A (en) *	1967-10-12	1971-01-19	Allied Chem	Fluorinated ethers as inhalation convulsants
IE67185B1 (en) *	1990-02-02	1996-03-06	Fisons Plc	Propellant compositions
US5605882A (en) *	1992-05-28	1997-02-25	E. I. Du Pont De Nemours And Company	Azeotrope(like) compositions of pentafluorodimethyl ether and difluoromethane
US5376359A (en) *	1992-07-07	1994-12-27	Glaxo, Inc.	Method of stabilizing aerosol formulations
GB9419536D0 (en) *	1994-09-28	1994-11-16	Glaxo Inc	Medicaments
CA2218179A1 (fr) *	1995-04-14	1996-10-17	Glaxo Wellcome Inc.	Inhalateur doseur de dipropionate de beclomethasone
US5874469A (en) *	1996-01-05	1999-02-23	Alcon Laboratories, Inc.	Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US5730894A (en) *	1996-04-16	1998-03-24	E. I. Du Pont De Nemours And Company	1,1,2,2,3,3,4,4-octafluorobutane azeotropic (like) compositions
US6458373B1 (en) *	1997-01-07	2002-10-01	Sonus Pharmaceuticals, Inc.	Emulsion vehicle for poorly soluble drugs
EP1014943B1 (fr) *	1997-02-05	2002-06-19	Jago Research Ag	Formulations medicales pour aerosols
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

2000
- 2000-07-11 GB GBGB0016876.5A patent/GB0016876D0/en not_active Ceased
2001
- 2001-07-10 IL IL15372601A patent/IL153726A0/xx unknown
- 2001-07-10 AT AT01952071T patent/ATE342048T1/de active
- 2001-07-10 EP EP01952071A patent/EP1303258B1/fr not_active Expired - Lifetime
- 2001-07-10 WO PCT/SE2001/001606 patent/WO2002003958A1/fr active IP Right Grant
- 2001-07-10 JP JP2002508413A patent/JP2004502719A/ja active Pending
- 2001-07-10 MX MXPA03000276A patent/MXPA03000276A/es active IP Right Grant
- 2001-07-10 BR BR0112322-0A patent/BR0112322A/pt not_active Application Discontinuation
- 2001-07-10 CN CN01815467A patent/CN1455663A/zh active Pending
- 2001-07-10 NZ NZ523379A patent/NZ523379A/en not_active IP Right Cessation
- 2001-07-10 DE DE60123793T patent/DE60123793T2/de not_active Expired - Lifetime
- 2001-07-10 US US10/332,568 patent/US20030194378A1/en not_active Abandoned
- 2001-07-10 CA CA002415092A patent/CA2415092A1/fr not_active Abandoned
- 2001-07-10 AU AU2001272866A patent/AU2001272866B2/en not_active Ceased
- 2001-07-10 DK DK01952071T patent/DK1303258T3/da active
- 2001-07-10 PT PT01952071T patent/PT1303258E/pt unknown
- 2001-07-10 AU AU7286601A patent/AU7286601A/xx active Pending
- 2001-07-10 KR KR10-2003-7000349A patent/KR20030025265A/ko not_active Ceased
- 2001-07-10 ES ES01952071T patent/ES2273864T3/es not_active Expired - Lifetime
2002
- 2002-12-29 IL IL153726A patent/IL153726A/en not_active IP Right Cessation
2003
- 2003-01-03 ZA ZA200300075A patent/ZA200300075B/en unknown
- 2003-01-10 NO NO20030133A patent/NO20030133L/no unknown
2007
- 2007-01-09 CY CY20071100028T patent/CY1105913T1/el unknown

Also Published As

Publication number	Publication date
DE60123793D1 (de)	2006-11-23
WO2002003958A1 (fr)	2002-01-17
EP1303258A1 (fr)	2003-04-23
MXPA03000276A (es)	2003-06-06
CA2415092A1 (fr)	2002-01-17
NZ523379A (en)	2004-06-25
GB0016876D0 (en)	2000-08-30
EP1303258B1 (fr)	2006-10-11
KR20030025265A (ko)	2003-03-28
IL153726A0 (en)	2003-07-06
NO20030133D0 (no)	2003-01-10
AU2001272866B2 (en)	2005-08-11
PT1303258E (pt)	2007-01-31
JP2004502719A (ja)	2004-01-29
AU7286601A (en)	2002-01-21
ES2273864T3 (es)	2007-05-16
US20030194378A1 (en)	2003-10-16
ZA200300075B (en)	2004-04-05
ATE342048T1 (de)	2006-11-15
BR0112322A (pt)	2003-07-08
IL153726A (en)	2008-07-08
CN1455663A (zh)	2003-11-12
CY1105913T1 (el)	2011-04-06
DE60123793T2 (de)	2007-09-06
DK1303258T3 (da)	2007-01-22

Publication	Publication Date	Title
NO20030133L (no)	2003-02-24	Ny aerosolformulering inneholdende et polart fluorert molekyl
ATE342053T1 (de)	2006-11-15	Formulierungen zur inhalation
DE69208660D1 (de)	1996-04-04	Fluorchlorkohlenwasserstoffreie aerosolformulierungen
EA199900991A1 (ru)	2000-08-28	Медицинские аэрозольные препараты
PT1014943E (pt)	2002-11-29	Formulacoes medicinais de aerossois
ATE505184T1 (de)	2011-04-15	Medizinische aerosolformulierung
NO20010391L (no)	2001-03-23	Medisinske aerosolformuleringer
DK1257254T3 (da)	2006-03-20	Formuleringer indeholdende et anticholinergt lægemiddel til behandling af kronisk obstruktiv lungesygdom
ATE215359T2 (de)	2002-04-15	Aerosolformulierungen
MXPA03000442A (es)	2003-06-24	Una formulacion medicinal en aerosol.
ATE343374T1 (de)	2006-11-15	Fluticasonpropionat arzneizubereitung
ECSP088732A (es)	2008-10-31	Aerosoles dosificadores para la administración de preparaciones farmacéuticas
TH29519B (th)	1998-08-14	สูตรผสมทางเภสัชศาสตร์ที่เสถียรชนิดใหม่สำหรับการผลิตละอองลอยที่ไม่มีแก๊สผลักดัน